Latest

2 stories

Hide weekly roundups

Tuesday, September 8

Sutro Biopharma registers Phase 1 first-in-human trial of ADC STRO-006 in solid tumors

Trial updateSTRO-006 Sutro Biopharma, Inc.

Wednesday, August 12

Clinical readoutSTRO-004 Sutro Biopharma, Inc.

Sutro Biopharma posts early STRO-004 responses, updates Q2 2026 financials

The company reported partial responses in its Phase 1 STRO-004 trial and said cash on hand should fund operations into at least Q2 2028.

SEC filing